Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Cell Mol Neurobiol ; 41(5): 1131-1143, 2021 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-33433723

RESUMO

Chronic administration of opioids produces physical dependence and opioid-induced hyperalgesia. Users claim the Thai traditional tea "kratom" and component alkaloid mitragynine ameliorate opioid withdrawal without increased sensitivity to pain. Testing these claims, we assessed the combined kratom alkaloid extract (KAE) and two individual alkaloids, mitragynine (MG) and the analog mitragynine pseudoindoxyl (MP), evaluating their ability to produce physical dependence and induce hyperalgesia after chronic administration, and as treatments for withdrawal in morphine-dependent subjects. C57BL/6J mice (n = 10/drug) were administered repeated saline, or graded, escalating doses of morphine (intraperitoneal; i.p.), kratom alkaloid extract (orally, p.o.), mitragynine (p.o.), or MP (subcutaneously, s.c.) for 5 days. Mice treated chronically with morphine, KAE, or mitragynine demonstrated significant drug-induced hyperalgesia by day 5 in a 48 °C warm-water tail-withdrawal test. Mice were then administered naloxone (10 mg/kg, s.c.) and tested for opioid withdrawal signs. Kratom alkaloid extract and the two individual alkaloids demonstrated significantly fewer naloxone-precipitated withdrawal signs than morphine-treated mice. Additional C57BL/6J mice made physically dependent on morphine were then used to test the therapeutic potential of combined KAE, mitragynine, or MP given twice daily over the next 3 days at either a fixed dose or in graded, tapering descending doses. When administered naloxone, mice treated with KAE, mitragynine, or MP under either regimen demonstrated significantly fewer signs of precipitated withdrawal than control mice that continued to receive morphine. In conclusion, while retaining some liabilities, kratom, mitragynine, and mitragynine pseudoindoxyl produced significantly less physical dependence and ameliorated precipitated withdrawal in morphine-dependent animals, suggesting some clinical value.


Assuntos
Analgésicos Opioides/efeitos adversos , Mitragyna , Dependência de Morfina/prevenção & controle , Alcaloides de Triptamina e Secologanina/administração & dosagem , Alcaloides de Triptamina e Secologanina/síntese química , Síndrome de Abstinência a Substâncias/prevenção & controle , Analgésicos Opioides/administração & dosagem , Animais , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Dependência de Morfina/metabolismo , Dependência de Morfina/psicologia , Medição da Dor/efeitos dos fármacos , Medição da Dor/métodos , Receptores Opioides delta/agonistas , Receptores Opioides delta/metabolismo , Receptores Opioides mu/agonistas , Receptores Opioides mu/metabolismo , Alcaloides de Triptamina e Secologanina/efeitos adversos , Alcaloides de Triptamina e Secologanina/isolamento & purificação , Síndrome de Abstinência a Substâncias/metabolismo , Síndrome de Abstinência a Substâncias/psicologia
2.
Curr Top Med Chem ; 11(9): 1165-75, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21050173

RESUMO

Mitragyna speciosa Korth. (Rubiaceae) is a tree that is commonly found in Southeast Asia. Leaves from this tree have been traditionally been used for both their stimulant properties as well as an opium substitute. The tree/leaves are currently illegal in four countries, but is currently legal and widely available in the United States. To date over 40 compounds have been isolated from the leaves. The major alkaloid found within the crude extract, mitragynine, has been the subject of many pharmacological studies. In addition to the pharmacological studies, two total syntheses of mitragynine have been published as well as general structure-activity relationships (SARs) with respect to opioid activity.


Assuntos
Analgésicos Opioides , Extratos Vegetais/farmacologia , Receptores Opioides/agonistas , Alcaloides de Triptamina e Secologanina , Alcaloides/síntese química , Alcaloides/farmacologia , Analgésicos Opioides/síntese química , Analgésicos Opioides/farmacologia , Animais , Sudeste Asiático , Relação Dose-Resposta a Droga , Cobaias , Humanos , Camundongos , Mitragyna/química , Folhas de Planta/química , Ratos , Receptores Opioides/metabolismo , Alcaloides de Triptamina e Secologanina/síntese química , Alcaloides de Triptamina e Secologanina/farmacologia , Relação Estrutura-Atividade , Estados Unidos
3.
Org Lett ; 8(8): 1733-5, 2006 Apr 13.
Artigo em Inglês | MEDLINE | ID: mdl-16597153

RESUMO

[structure: see text] A new indole alkaloid, arboflorine, possessing a novel pentacyclic carbon skeleton and incorporating a third nitrogen atom was obtained from the Malayan Kopsia arborea. The structure was established by spectroscopic analysis, and a possible biogenetic pathway from a preakuammicine-type precursor is presented.


Assuntos
Nitrogênio/química , Alcaloides de Triptamina e Secologanina/síntese química , Malásia , Estrutura Molecular , Plantas Medicinais/química , Alcaloides de Triptamina e Secologanina/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA